BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

AVer Introduces Revolutionary Detachable Medical Grade Cameras

AVer launches its newest Medical Grade PTZ Cameras, the MD330U and MD330UI, as the trend for Telemedicine, patient monitoring, and Live Surgery Broad...

August 02, 2022 | News

Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects

PrecisemAb Biotech, a biotechnology research company based in Kaohsiung, Taiwan, continues to stay true to its vision of enhancing antibody drug...

August 01, 2022 | News

BIO Asia–Taiwan 2022 kicks off

With pandemic restrictions continuing to make travel to Taiwan a difficult proposition, allconference sessions as well as the exhibition, company presentat...

July 29, 2022 | News

Merck Launches its Uptune Program in Asia for Collaborating with Startups

Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologi...

July 15, 2022 | News

TFBS will leverage the scale-X™ carbo mid-scale fixed-bed bioreactor from Univercells Technologies

TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacific region providing the first...

July 15, 2022 | News

BRIM Biotechnology enters OTC trading in Taiwan

Established in July 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative j...

June 24, 2022 | News

BIO Asia-Taiwan 2022 kicks off July 27 with theme 'Connecting the Asian Value Chain'

During a press event on June 8, 2022, the Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BI...

June 14, 2022 | News

United BioPharma Receives TFDA Approval for Phase 2 IND for UB-221 to Treat Chronic Spontaneous Urticaria

This Phase 2 clinical trial (double-blind, placebo-controlled) aims to evaluate the efficacy of UB-221 as a long-acting add-on therapy for treatment of chr...

May 31, 2022 | News

Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutralizing efficacy

AcadeMab's treatment specifically targets the SARS-CoV-2 Omicron variant – currently the most common strain of COVID infections around the world. "I...

May 30, 2022 | News

BIO Asia–Taiwan 2022 : Connecting the Asian Value Chain

This year BIO Asia–Taiwan 2022 Onsite + Online will be held in Taipei, Taiwan from July 27-31 in a mixed live + online forma...

May 25, 2022 | News

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of ...

May 11, 2022 | News

Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries

Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its comme...

February 16, 2022 | News

Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tra...

January 04, 2022 | News

Healthcare+ Expo Taiwan to Build an Ecosystem of Digital Transformation in Healthcare

Expand Businesses into growing markets in the APAC region, with Healthcare+ B2B. Join medical institutes and companies in the fields of pharmaceuticals, bi...

December 06, 2021 | News

Stay Connected